Shares of DIAGNOS Inc. (OTCMKTS:DGNOF – Get Free Report) dropped 2.7% on Tuesday. The stock traded as low as $0.2160 and last traded at $0.2160. Approximately 7,500 shares traded hands during trading, a decline of 88% from the average daily volume of 60,291 shares. The stock had previously closed at $0.2220.
DIAGNOS Stock Down 14.2%
The firm has a 50-day moving average of $0.29 and a two-hundred day moving average of $0.22. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.33.
DIAGNOS Company Profile
DIAGNOS Inc. is a Canadian healthcare technology company focused on using artificial intelligence and image analysis to support eye-care screening. Its CARA platform analyzes retinal images to help identify signs of eye disease and assist healthcare professionals with patient assessment. The company provides retinal screening solutions for clinics and other healthcare settings, including options suited to remote screening. Its technology is intended to support clinical review and referral, not replace diagnosis by a qualified healthcare professional.
Recommended Stories
- Five stocks we like better than DIAGNOS
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.
